Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
332.54
-2.52 (-0.75%)
Sep 30, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $9.86 billion as of September 30, 2026. Its market cap has increased by 92.73% in one year.
Market Cap
9.86B
Enterprise Value
8.77B
1-Year Change
92.73%
Ranking
Category
Stock Price
$332.54
ChartMarket Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $9.86B, an increase of 10,570.64%. That is a compound annual growth rate of 67.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.86B | 37.92% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 11.51B |
| Bio-Techne | 11.37B |
| Twist Bioscience | 11.26B |
| Axsome Therapeutics | 10.16B |
| Kymera Therapeutics | 9.31B |
| Arrowhead Pharmaceuticals | 9.25B |
| Protagonist Therapeutics | 9.22B |
| Cytokinetics | 9.20B |